These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7926284)

  • 1. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats.
    Balkan B; Dunning BE
    Diabetes; 1994 Oct; 43(10):1173-9. PubMed ID: 7926284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus.
    Shankar RR; Zhu JS; Baron AD
    Metabolism; 1998 May; 47(5):573-7. PubMed ID: 9591749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production.
    Barzilai N; Hawkins M; Angelov I; Hu M; Rossetti L
    Diabetes; 1996 Oct; 45(10):1329-35. PubMed ID: 8826967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2.
    Yoshikawa H; Tajiri Y; Sako Y; Hashimato T; Umeda F; Nawata H
    Pancreas; 2002 Apr; 24(3):228-34. PubMed ID: 11893929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glucose-stimulated insulin release by pseudo-alpha-DL-glucose as a glucokinase inhibitor.
    Miwa I; Hara H; Okuda J; Suami T; Ogawa S
    Biochem Int; 1985 Dec; 11(6):809-16. PubMed ID: 3911958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP.
    Abdel-Halim SM; Guenifi A; Khan A; Larsson O; Berggren PO; Ostenson CG; Efendić S
    Diabetes; 1996 Jul; 45(7):934-40. PubMed ID: 8666145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.
    Radu RG; Fujimoto S; Mukai E; Takehiro M; Shimono D; Nabe K; Shimodahira M; Kominato R; Aramaki Y; Nishi Y; Funakoshi S; Yamada Y; Seino Y
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E365-71. PubMed ID: 15479952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine-induced insulin release in glucokinase-deficient subjects.
    Pueyo ME; Clement K; Vaxillaire M; Passa P; Froguel P; Robert JJ; Velho G
    Diabetes Care; 1994 Sep; 17(9):1015-21. PubMed ID: 7988299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucose-induced insulin secretion through inactivation of glucokinase by glyceraldehyde.
    Murata T; Miwa I; Toyoda Y; Okuda J
    Diabetes; 1993 Jul; 42(7):1003-9. PubMed ID: 8513967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
    Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
    J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
    Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
    Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term glucosamine infusion increases islet blood flow in anesthetized rats.
    Gao X; Jansson L; Persson AE; Sandberg M
    Islets; 2013; 5(5):201-6. PubMed ID: 24275157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas.
    Nesher R; Eylon L; Segal N; Cerasi E
    Endocrinology; 1989 Jan; 124(1):142-8. PubMed ID: 2462485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research.
    Polonsky KS
    Diabetes; 1995 Jun; 44(6):705-17. PubMed ID: 7789637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
    Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
    Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucosamine-induced desensitization of beta-cell responses: possible involvement of impaired information flow in the phosphoinositide cycle.
    Zawalich WS; Zawalich KC
    Endocrinology; 1992 Jun; 130(6):3135-42. PubMed ID: 1317776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
    Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by glucose of insulin secretion and glucose phosphorylating activity in cultured pancreatic islets from obese (fa/fa) Zucker rats.
    Chan CB; Lowe JM; Debertin WJ
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):175-84. PubMed ID: 8646255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.